Cargando…
Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
BACKGROUND: Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence. OBJECTIVE: The aim of this study was to elucidate t...
Autores principales: | Katzmann, Julius L, Mahfoud, Felix, Böhm, Michael, Schulz, Martin, Laufs, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302826/ https://www.ncbi.nlm.nih.gov/pubmed/30587940 http://dx.doi.org/10.2147/PPA.S182765 |
Ejemplares similares
-
Why doesn’t high cholesterol hurt?
por: Katzmann, Julius L., et al.
Publicado: (2019) -
Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
por: Katzmann, Julius L., et al.
Publicado: (2022) -
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
por: Packard, Chris, et al.
Publicado: (2021) -
Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk
por: Katzmann, Julius L., et al.
Publicado: (2022) -
Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol
por: Pedersen, Elisabeth, et al.
Publicado: (2022)